Learning Center

Learning Center

Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Includes Multiple Live Events. The next is on 09/21/2024 at 10:00 AM (EDT)

    Course Date: September 21 & 22, 2024. The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.

    Course Date

    September 21 & 22, 2024.


    Course Description

    The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.


    Target Audience

    The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD/IOF Osteoporosis Essentials for Technologists Course.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    • Describe appropriate clinical evaluation of patients at risk for fragility fracture.
    • Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD. 
    • Recognize errors in DXA analysis and reporting. 
    • Explain new and emerging guidelines that provide evidence-based information regarding skeletal health. 
    • Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.

    Method of Participation

    This activity will be offered live streamed via Zoom, allowing the learner to watch and ask questions in a live format on September 21 & 22, 2024. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

    Rates


    image


    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

     Schedule - Day 1 - All times Eastern Standard Time (NYC/USA)
    image


     Schedule - Day 2 -All times Eastern Standard Time (NYC/USA)

    image


    Course Planning Committee

    Neil Binkley, MD, CCD, CBDT - Consulting Fee: Amgen; Contracted Research: Radius 
    Sarah Morgan, MD, RD, CCD - No Financial Relationships to Disclose 
    Steven Petak, MD, JD, MACE, FACP, CCD - Fees for Non-CME Services: Amgen, Alexion
    Christopher Shuhart, MD, CCD - No Financial Relationships to Disclose
    S. Bobo Tanner, MD, CCD - Consulting Fees: AMGA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen 

    Course Content Reviewers

    Carolyn Crandall, MD, CCD - No Financial Relationships to Disclose 
    Monique Carroll, RT, CBDT - No Financial Relationships to Disclose 
    Brian Englander, MD - No Financial Relationships to Disclose 
    Ranjodh Gill, MD, CCD - No Financial Relationships to Disclose 
    Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT - No Financial Relationships to Disclose
    Adrian Lau, MD, FRCPC, MScCH, - CCD No Financial Relationships to Disclose 
    Orhan Oz, MD, PhD, CCD - No Financial Relationships to Disclose

    December 2023 Course Faculty

    Christopher R. Shuhart, MD, MHA - No Financial Relationships to Disclose
    Neil Binkley, MD, CCD, CBDT - Consulting Fee: Amgen; Contracted Research: Radius 
    S. Bobo Tanner, MD, CCD Disclosures: Consulting Fees: AMGA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Includes Multiple Live Events. The next is on 12/09/2023 at 10:00 AM (EST)

    Course Date: December 9 & 10, 2023. The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative. The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.

    Course Date

    December 9 & 10, 2023.


    Course Description

    The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative.  The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.


    Target Audience

    The course is most appropriate for those involved in the performance of DXA scans and open to any health professional performing these scans.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Design and implement quality control and assurance practices.
    2. Perform a precision assessment and appreciate the requirement for clinical care.  
    3. Identify the anatomy relevant to clinical DXA scanning. 
    4. Implement consistent and appropriate technical acquisition and analysis techniques.  
    5. Perform a fracture risk assessment using FRAX. 
    6. Provide DXA interpreters sufficient information for a high-quality DXA report. 
    7. Discuss supplemental software and their application.
    8. Demonstrate how to access features within the DXA software. 
    9. Understand how specific medical conditions and medications affect bone density. 
    10. Critically evaluate DXA scans to identify acquisition and analysis errors and implement resolution methods.
    11. Recognize how technical errors impact clinical interpretation and patient care.



      Method of Participation

      This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on December 9 & 10, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

      Registration Fee

      image



      Cancellation Policy

      Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

      ASRT Credit Designation: 

      This activity has been approved by ASRT for 13.0 Category A continuing education credits.

      Date of most recent Review or Update: This activity was most recently reviewed and renewed March 24, 2023.

      ASRT Credit Notice

      This course is a renewal. If you have previously taken this course, you will not be able to claim ASRT again for this learning activity.

      Deadline to Claim Credit:

      Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

      Schedule - Day 1 - All times Eastern (NYC/USA)

      image

      Schedule - Day 2 - All times Eastern (NYC/USA)

      image

      Maureen A. Costello, AAS, RT(R), CBDT

      Radiologic Technologist

      University of Chicago Hospitals

      Maureen has been a Radiologic Technologist for the past 25 years. As a diagnostic Rad. Tech., she specialized in Trauma and Surgical radiography at one of two Trauma Centers in the greater Chicago land area, and then moved into Orthopedic Radiography before moving onto DXA in 2003. She is the Lead Tech. At the University of Chicago Hospitals, Dept. of Endocrinology. While the bulk of her day consists of performing BMD’s, she is also responsible for QA/QC of equipment and reports, monitoring and performing multiple studies and on-site training of not only office staff but also tutorials for 4th year Med. Students. Maureen has been certified since 2003 and has been an instructor with the ISCD since 2007.

      Disclosure: No Financial Relationships to Disclose

      Anita Colquhoun, RTNM, MRT(N), CDT

      Charge Technologist

      Women's College Hospital

      Anita Colquhoun M.R.T.(N), CDT is the charge technologist in the Centre for Osteoporosis & Bone Health at the Women’s College Hospital in Toronto. Anita is a Nuclear Medical Technologist specialized in Bone Mineral Density (BMD). She has been working in the field of BMD since the early 1990s. Anita is an active member ISCD Technologist Faculty since 2000. She has served 2 terms on the Governing Board of the ISCD and is currently serving her third term as the Executive Secretary to the Board. As well as Chairing then Annual Meeting Committee from 2012-2016 Anita served and is still serving on several other committees within the ISCD. She has participated in a variety of research studies and has co-authored abstracts and papers. Anita has also co-written an on-line beginner BMD course as well as developed a competency profile and best practise in BMD for the Ontario Association of Medical Radiation Sciences.

      Disclosure: No Financial Relationships to Disclose.

      Diane Krueger, BS, CBDT

      Program Manager Osteoporosis Clinical Research Program

      UW Osteoporosis Clinic

      Diane Krueger received her Bachelor of Science degree at the University of Wisconsin-Madison. She is an ISCD-certified clinical densitometrist and a certified clinical research coordinator through the Association of Clinical Research Professionals. She has been program manager of the University of Wisconsin Osteoporosis Clinical Research Program since its inception in 1993. Ms. Krueger has extensive clinical research experience in osteoporosis and bone densitometry, having coordinated multiple industry and investigator-initiated studies. In collaboration with the UW Osteoporosis Program, she has published over 90 manuscripts and authored or presented over 200 abstracts. Her service with ISCD has included serving as Technologist Bone Densitometry Course faculty since 2006 and chairing the related Update Annual Meeting Committees. In her leadership capacity, she is currently Education Council chair and serves on the Executive Committee and Board. Additionally, she previously held several officer positions including Secretary and four Presidential seats.

      Disclosures: Consulting Fee: Amgen and Radius; Contracted Research: Amgen and Radius 

      Course Planning Committee

      JoAnn Caudill, RT(R)(M)(BD), CBDT  No Financial Relationships to Disclose 
      Anita Colquhoun, RTNM, MRT(N), CDT No Financial Relationships to Disclose 
      Larry G. Jankowski, CBDT No Financial Relationships to Disclose
      Greg Yardley, MSRS, RT(R), CBDT No Financial Relationships to Disclose
      Michelle Kochanski ,BSIT, RT(R), CBDT No Financial Relationships to Disclose 
      Diane Krueger, BS, CBDT Consulting Fee: Amgen; Contracted Research: Radius

      Course Content Reviewers

      Carolyn Crandall, MD, CCD No Financial Relationships to Disclose 
      Monique Carroll, RT, CBDT No Financial Relationships to Disclose 
      Brian Englander, MD No Financial Relationships to Disclose 
      Ranjodh Gill, MD, CCD No Financial Relationships to Disclose 
      Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT No Financial Relationships to Disclose
      Adrian Lau, MD, FRCPC, MScCH, CCD No Financial Relationships to Disclose 
      Orhan Oz, MD, PhD, CCD  No Financial Relationships to Disclose

      December 2023 Course Faculty

      Maureen A. Costello, AAS, RT(R), CBDT No Financial Relationships to Disclose
      Anita Colquhoun, RTNM, MRT(N), CDT No Financial Relationships to Disclose
      Diane Krueger, BS, CBDT Disclosures: Consulting Fee: Amgen; Contracted Research: Radius 

      image

      Statement of Independence

      The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

      Disclaimer

      The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

      Disclosure of Unlabeled Use

      This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

      Privacy & Confidentiality Statement

      The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

      Attendance Cancellation Policy

      All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations

      ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    1. Includes Multiple Live Events. The next is on 12/09/2023 at 10:00 AM (EST)

      Course Date: December 9 & 10, 2023. The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.

      Course Date

      December 9 & 10, 2023.


      Course Description

      The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.


      Target Audience

      The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD/IOF Osteoporosis Essentials for Technologists Course.


      Learning Objectives

      After attending the course, participants should be better prepared to:

      • Describe appropriate clinical evaluation of patients at risk for fragility fracture.
      • Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD. 
      • Recognize errors in DXA analysis and reporting. 
      • Explain new and emerging guidelines that provide evidence-based information regarding skeletal health. 
      • Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.

      Method of Participation

      This activity will be offered live streamed via Zoom, allowing the learner to watch and ask questions in a live format on December 9 & 10, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

      Rates


      image


      Cancellation Policy

      Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

      ACCME Accreditation Statement:

      The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

      AMA PRA Category 1 Credit(s)™

      The International Society for Clinical Densitometry designates this live educational activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

      Deadline to Claim Credit:

      Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

       Schedule - Day 1 - All times Eastern Standard Time (NYC/USA)
      image


       Schedule - Day 2 -All times Eastern Standard Time (NYC/USA)

      image


      Dr Neil Binkley MD, CCD

      Professor

      University of Wisconsin Madison

      Dr. Neil Binkley earned his medical degree from the University of Wisconsin and subsequently trained in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin and completed a Geriatrics fellowship. He is a Professor in the Divisions of Geriatrics and Endocrinology at the University of Wisconsin School of Medicine and Public Health. He is also Director of the UW Osteoporosis Clinical Research Program and Associate Director of the UW Institute on Aging. He is past President of the International Society for Clinical Densitometry, Associate Editor of Osteoporosis International and a member of the International Osteoporosis Foundation Committee of Scientific Advisors. His current research involves improvement in 25(OH)D measurement, evaluation of approaches to optimize assessment of vitamin D status, evaluation of functional assessment in older adults and the importance of sarcopenia in fracture risk. Dr. Binkley has published over 300 papers, served on expert committees and panels for AACE, ASBMR, IOF and ISCD.

      Disclosure(s): Amgen: Consulting Fee, Contracted Research; Radius: Contracted Research 

      Christopher Shuhart MD, MHA, CCD

      Director of the Bone Health and Osteoporosis Center

      Swedish Medical Group

      Dr. Shuhart is the founder and Director of the Bone Health and Osteoporosis Center at Swedish Medical Group in Seattle, Washington. He is Past-President of the International Society for Clinical Densitometry (ISCD) from 2019-2020, with multiple years in Executive and Board of Directors roles, and has served on numerous ISCD committees and task forces. He received ISCD's Paul Miller Service Award in 2022.

      He is a co-author on the ISCD’s 2016 publication of “Best Practices” in the Journal of Clinical Densitometry, and was the Organizing Chair for the 2019 ISCD Position Development Conference (PDC) in Kuala Lumpur, Malaysia, as well as lead author of the 2019 PDC Executive Summary. He is the Administrative Chair for the 2023 PDC.

      Dr. Shuhart received his medical degree from Dartmouth Medical School in 1987, and his Masters in Health Administration from the University of Washington in 2009. He is board certified in Family Medicine since 1990.

      Disclosure: No financial relationships to disclose

      S. Bobo Tanner, MD, CCD

      Director of the Vanderbilt Osteoporosis Clinic

      Vanderbilt University Medical Center

      Bobo Tanner, MD, CCD is an Assistant Professor of Medicine at Vanderbilt University Medical Center in Nashville, TN in the Divisions of Rheumatology, Allergy and Immunology. He is the Director of the Vanderbilt Osteoporosis Clinic. His education includes an AB from Harvard University, and an MD from Wake Forest University. He completed his training in Internal Medicine, Rheumatology, and Allergy & Immunology at Vanderbilt University and served as Registrar in Rheumatology at the Royal Free Hospital, London, England. Dr. Tanner has been a member of the International Society for Clinical Densitometry (ISCD) since 1996 and is a Past- President of the ISCD. He is an Osteoporosis Essentials Course instructor, serves on the OE Update Committee and CME Committee. He was awarded Clinical Densitometrist of the year in 2007 by the ISCD and was Co-Chair of the ISCD Annual Meeting in 2006. He is a reviewer for the Journal of Clinical Densitometry and is on the editorial board of Therapeutic Advances in Musculoskeletal disease. He has also participated in numerous advisory boards and has given a variety of CME presentations. His research has been presented in regional, national, and international academic meetings.

      Disclosures: Consulting Fees: AMGA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen

      Course Planning Committee

      Neil Binkley, MD, CCD, CBDT - Consulting Fee: Amgen; Contracted Research: Radius 
      Sarah Morgan, MD, RD, CCD - No Financial Relationships to Disclose 
      Steven Petak, MD, JD, MACE, FACP, CCD - Fees for Non-CME Services: Amgen, Alexion
      Christopher Shuhart, MD, CCD - No Financial Relationships to Disclose
      S. Bobo Tanner, MD, CCD - Consulting Fees: AMGA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen 

      Course Content Reviewers

      Carolyn Crandall, MD, CCD - No Financial Relationships to Disclose 
      Monique Carroll, RT, CBDT - No Financial Relationships to Disclose 
      Brian Englander, MD - No Financial Relationships to Disclose 
      Ranjodh Gill, MD, CCD - No Financial Relationships to Disclose 
      Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT - No Financial Relationships to Disclose
      Adrian Lau, MD, FRCPC, MScCH, - CCD No Financial Relationships to Disclose 
      Orhan Oz, MD, PhD, CCD - No Financial Relationships to Disclose

      December 2023 Course Faculty

      Christopher R. Shuhart, MD, MHA - No Financial Relationships to Disclose
      Neil Binkley, MD, CCD, CBDT - Consulting Fee: Amgen; Contracted Research: Radius 
      S. Bobo Tanner, MD, CCD Disclosures: Consulting Fees: AMGA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen

      image

      Statement of Independence

      The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

      Disclaimer

      The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

      Disclosure of Unlabeled Use

      This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

      Privacy & Confidentiality Statement

      The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

      Attendance Cancellation Policy

      All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations

      ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    2. Includes Multiple Live Events. The next is on 12/03/2023 at 10:00 AM (EST)

      Course Date: December 3, 2023. This advanced densitometry course focuses on how vertebral fracture imaging advances the diagnosis and treatment of patients at risk of osteoporotic fractures. It emphasizes the importance of vertebral fractures in the clinical management of osteoporosis, including recognition of lateral spine images of a normal spine, vertebral fractures, and other findings that may be confused with vertebral fractures. Fracture recognition, analysis, and best-practice patient positioning are detailed to ensure ideal image acquisition, interpretation, and reporting.

      Course Date

      December 3, 2023

      Course Description

      This advanced densitometry course focuses on how vertebral fracture imaging advances the diagnosis and treatment of patients at risk of osteoporotic fractures. It emphasizes the importance of vertebral fractures in the clinical management of osteoporosis, including recognition of lateral spine images of a normal spine, vertebral fractures, and other findings that may be confused with vertebral fractures.  Fracture recognition, analysis, and best-practice patient positioning are detailed to ensure ideal image acquisition, interpretation, and reporting. It is recommended, but not required, that registrants attend the Osteoporosis Essentials/Quality Bone Densitometry Course (Clinician or Technologist) prior to attending the VFR course


      Target Audience

      The content is designed for healthcare providers responsible for reading and interpreting DXA scans, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, nuclear medicine, physical and occupational therapy, and research. The course is also appropriate for technologists.


      Learning Objectives

      After attending the course, participants should be better prepared to:

      1. Summarize best-practice methods utilized to recognize vertebral fractures on lateral spine images. 2. Describe non-fracture abnormalities that may appear on a spine image. 3. Identify characteristics of high-quality densitometric lateral spine images. 4. Identify the appropriate complementary technologies to complete vertebral fracture assessment. 5. Cite indications for VFA as stated in the 2015 ISCD Official Positions.

      Method of Participation

      This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on December 3, 2023. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 


      Rates

      image

      Cancellation Policy

      Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

      ACCME Accreditation Statement:

      The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

      AMA PRA Category 1 Credit(s)™

      The International Society for Clinical Densitometry designates this live educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

      ASRT Credit Designation: 

      This activity has been approved by ASRT for 4.5 Category A continuing education credits.

      Date of Original Release and most recent Review or Update: This activity was most recently reviewed and released on July 25, 2022.

      Deadline to Claim Credit:

      Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

      Schedule - December 3, 2023 - All times eastern (NYC/USA)

      image


      John Schousboe, MD, PhD, CCD

      Director, Park Nicollet Bone Densitometry Center; Consultant Rheumatologist, Park Nicollet Clinic; Research Investigator, HealthPartners Institute

      Dr. Schousboe is a rheumatologist and health services researcher who directs the bone densitometry center of Park Nicollet Clinic, a large integrated health care delivery system in Minneapolis, MN. He is an a Past President of the International Society for Clinical Densitometry (ISCD) and a Fellow of the American Society for Bone and Mineral Research (ASBMR). During a 16-year research career he has been an author on 200 peer-reviewed publications, the far majority of which have been in the field of diagnosis and management of osteoporosis. His contributions to science include development of a cost-effectiveness model that was used to conduct studies of the cost-effectiveness of bone densitometry in men and subgroups of older women and men defined by prevalent vertebral fracture, bone turnover marker levels, and bone density level; studies of the accuracy, prevalence, and clinical impact of vertebral fracture recognition on bone density lateral spine images; studies of medication adherence to osteoporosis therapies; studies of the identification and clinical significance of abdominal aortic calcification on lateral bone density spine images; and predictors of health care utilization and costs using Medicare Claims data.

      No Financial Relationships to Disclose 

      E. Michael Lewiecki, MD, FACP, FACE, CCD

      Director

      New Mexico Clinical Research & Osteoporosis Center, Inc.

      E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health TeleECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.

      Disclosures: Amgen (Self) : Consultant (Status: Ongoing), Research Support (Status: Ongoing), Speaker's Bureau / Teaching Engagements (Status: Ongoing); Radius (Self) : Research Support (Status: Ongoing)

      Course Planning Committee

      Tamara Vokes, MD, CCD No Financial Relationships to Disclose
      Brad Richmond, MD, FACR,CCD No Financial Relationships to Disclose
      John Schouseboe, MD, PhD, CCD No Financial Relationships to Disclose
      Harold Rosen, MD, CCD No Financial Relationships to Disclose
      Edwin Oei, MD, PhD No Financial Relationships to Disclose

      Course Content Reviewers

      Campbell Macgregor, CCD No Financial Relationships to Disclose
      Kelly Molinar-Kagan, RT(R)(M) CBDT No Financial Relationships to Disclose
      Monique Carroll, RT, CBDT No Financial Relationships to Disclose
      Merle Wigeson, MD No Financial Relationships to Disclose

      December 2023 Course Faculty

      John Schousboe, MD, PhD, CCD No Financial Relationships to Disclose
      E. Michael Lewiecki, MD, FACP, FACE Disclosures: Amgen (Self) : Consultant (Status: Ongoing), Research Support (Status: Ongoing), Speaker's Bureau / Teaching Engagements (Status: Ongoing); Radius (Self) : Research Support (Status: Ongoing)

      image

      Statement of Independence

      The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

      Disclaimer

      The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

      Disclosure of Unlabeled Use

      This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

      Privacy & Confidentiality Statement

      The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

      Attendance Cancellation Policy

      All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations

      ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    3. Includes Multiple Live Events. The next is on 11/04/2023 at 10:00 AM (EDT)

      Course Date: November 4, 2023. This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.

      Course Date

      November 4, 2023

      Course Description

      This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.

      Target Audience

      The content is designed for healthcare providers responsible for reading and interpreting DXA scans, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, physical and occupational therapy, and research, as well as technologists.

      Learning Objectives

      After attending the course, participants should be better prepared to:

      1. Identify proper DXA technology for body composition analysis of fat, lean muscle and bone mass.
      2. List other methods of body composition analysis used in the clinical setting.
      3. Differentiate reference values and indices.
      4. Identify limitations of reference values and indices.
      5. Summarize scan acquisition for adult and pediatric patients.

      Method of Participation

      This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on November 4, 2023. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 

      Rates

      image


      Cancellation Policy

      Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

      ACCME Accreditation Statement:

      The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

      AMA PRA Category 1 Credit(s)™

      The International Society for Clinical Densitometry designates this live educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

      ASRT Credit Designation: 

      This activity is pending ASRT approval.

      Date of Original Release and most recent Review or Update: This activity was most recently reviewed and released on July 25, 2022.

      Deadline to Claim Credit:

      Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

      Schedule - November 4, 2023 - All times eastern (NYC/USA)
      image


      Adam Kuchnia

      Assistant Professor at the University of Wisconsin-Madison

      Adam Kuchnia is an Assistant Professor at the University of Wisconsin-Madison in the Department of Nutritional Sciences and holds a joint appointment within the Department of Surgery at the University of Wisconsin School of Medicine and Public health. The overall goal of his laboratory is to use a translational research approach to understand the mechanisms involved in the pathogenesis and the clinical implications of myosteatosis (i.e. muscle quality), or the infiltration of fat within muscle tissue, in aging and age-related disease. He has expertise in various imaging modalities for the assessment of muscle and in protein/muscle metabolism. Currently, his research focuses on human nutrition, in vivo lean tissue/muscle imaging and ex vivo measures to assess muscle and metabolic dysfunction. Adam is particularly interested in novel applications to refine protein recommendations with the goal of preserving muscle mass and muscle quality, while preventing consequential outcomes seen in aging and age-related disease. His research also aims to develop novel, noninvasive methods to accurately detect muscle wasting and myosteatosis and monitor changes in skeletal muscle while optimizing therapeutic intervention throughout medical treatment and surgery, including chemotherapy/immunotherapy and transplantation.

      No financial relationships to disclose

      John Shepherd PhD, CCD

      Researcher/Professor at the UH Cancer Center

      John Shepherd is a Researcher/Professor at the University of Hawaii Cancer Center, a Fulbright Scholar and an expert in mining biomarkers from medical imaging using advanced machine learning techniques; Co-I San Francisco Mammography Registry 1999-2018; PI of the NIH-funded 3-Component Breast Imaging Study; Director of the Artificial Intelligence Precision Health Institute, the Body Composition Exercise Physiology and Energy Metabolism CORE lab, and the Shepherd Research Lab; 2017 President of the International Society for Clinical Densitometry; ISCD’s John Bilezikian Global Leadership and Oscar Gluck Humanitarian Awards for his IAEA contributions. He has chaired 10 international workshops on quantitative imaging and has over 200 peer-reviewed publications that have been referenced over 10,000 times.

      Disclosure(s): GE Healthcare: Contracted Research (PI’s must provide disclosure in this category) (Ongoing); Hologic, Inc: Contracted Research (PI’s must provide disclosure in this category) (Ongoing)

      Course Planning Committee

      Ian Entwistle No Financial Relationships to Disclose
      Karen Hind, PhD, No Financial Relationships to Disclose
      Gary Slater No Financial Relationships to Disclose
      Michelle Swainson, BSc, MSc, PhD No Financial Relationships to Disclose
      Greg Yardley, MSRS, RT(R), CBDT No Financial Relationships to Disclose

      Course Content Reviewers

      Suresh Kumar, MD, CCD No Financial Relationships to Disclose
      William Leslie, MD, FRCPC, MSc, CCD No Financial Relationships to Disclose
      Kelly Molinar-Kagan, RT(R)(M), CBDT No Financial Relationships to Disclose
      Vani Selvan, MD, CCD No Financial Relationships to Disclose

      November 2023 Course Faculty

      Adam Kuchina No Financial Relationships to Disclose
      Dr. John A. Shepherd, PhD, CCD Contracted Research- Hologic, Inc-Investigator Initiated Study; GE Healthcare-Investigator Initated Study; Ownership Interest-BodySpec-Stock Options for Scientific Advisory Board

      image

      Statement of independence

      The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

      Disclaimer

      The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

      Disclosure of Unlabeled Use

      This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

      Privacy & Confidentiality Statement

      The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

      Attendance Cancellation Policy

      All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations

      ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    4. This activity was designed to allow learners to understand when vitamin D is helpful in optimizing bone health, which preparations are the best to use, and which dosing regimen is most advantageous. Attendees can listen to a clear lecture by one of the leaders in the field of vitamin D and understand the state of the art of how and when to dose vitamin D most effectively.

      Activity approved for 1.00 ASRT Category A Credits
      Activity approved for up to 1.0 AMA PRA Category 1 Credits™ 
      Activity Expires October 1, 2024

      Activity Description

      This activity was designed to allow learners to understand when vitamin D is helpful in optimizing bone health, which preparations are the best to use, and which dosing regimen is most advantageous. Attendees can listen to a clear lecture by one of the leaders in the field of vitamin D and understand the state of the art of how and when to dose vitamin D most effectively.

      Learning Objectives:

      1. Identify under which circumstances vitamin D is helpful
      2. Understand which vitamin D preparation is most useful
      3. Understand which vitamin D treatment regimen and schedule is most helpful

      Instructions:

      Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

      Registration Fees

      image

      Cancellation Policy

      On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable. 

      On-Demand/Enduring Material Program Changes or Cancellations  ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

      ACCME Accreditation Statement

      The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

      AMA PRA Category 1 Credit(s)™

      The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

      ASRT Credit Designation 

      This activity has been approved by ASRT for 1.00 Category A continuing education credits.

      Date of Original Release and most recent Review or Update 

      This activity was most recently reviewed and released on September 1, 2023, and will expire on October 1, 2024.

      Dr Neil Binkley MD, CCD

      Professor

      University of Wisconsin Madison

      Dr. Neil Binkley earned his medical degree from the University of Wisconsin and subsequently trained in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin and completed a Geriatrics fellowship. He is a Professor in the Divisions of Geriatrics and Endocrinology at the University of Wisconsin School of Medicine and Public Health. He is also Director of the UW Osteoporosis Clinical Research Program and Associate Director of the UW Institute on Aging. He is past President of the International Society for Clinical Densitometry, Associate Editor of Osteoporosis International and a member of the International Osteoporosis Foundation Committee of Scientific Advisors. His current research involves improvement in 25(OH)D measurement, evaluation of approaches to optimize assessment of vitamin D status, evaluation of functional assessment in older adults and the importance of sarcopenia in fracture risk. Dr. Binkley has published over 300 papers, served on expert committees and panels for AACE, ASBMR, IOF and ISCD.

      Disclosure(s): Amgen: Consulting Fee, Contracted Research; Radius: Contracted Research 

      Course Planners and Managers

      Fiore Barbini - No Financial Relationships to Disclose

      Jill Seely, BS, CAHI, CMA - No Financial Relationships to Disclose

      Harold Rosen, MD, CCD -  No Financial Relationships to Disclose

      Course Content Reviewers

      Wendy Tolman-Andrews -  No Financial Relationships to Disclose

      Content Authors

      Dr Neil Binkley, MD, CCD - Disclosure(s): Amgen: Consulting Fee, Contracted Research; Radius: Contracted Research

      image

      Statement of Independence

      The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

      Disclaimer

      The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

      Disclosure of Unlabeled Use 

      This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      Privacy & Confidentiality Statement

      The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

      Attendee Cancellation Policy

      All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

      Course Changes or Cancellations

      ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

    5. This activity will give an update on diagnosis and indications for surgery with a focus on bone. This activity was designed to allow learners to understand how to approach which patients to refer for surgery for hyperparathyroidism.

      Activity approved for 1.0 ASRT Category A Credits
      Activity approved for up to 1.0 AMA PRA Category 1 Credits™
      Activity Expires August 1, 2024

      Activity Description

      This activity will give an update on diagnosis and indications for surgery with a focus on bone. This activity was designed to allow learners to understand how to approach which patients to refer for surgery for hyperparathyroidism.

      Learning Objectives

      1. The attendee will understand the current guidelines for when to refer patients with hyperparathyroidism for surgery.

      2. The attendee will understand that in patients with eGFR<60, hyperparathyroidism is a more aggressive disease and warrants surgery.

      3. The attendee will understand that there is no clear benefit to quality of life parameters associated with parathyroidectomy.

      Instructions

      Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

      Registration Fees

      image

      Cancellation Policy

      On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable. 

      On-Demand/Enduring Material Program Changes or Cancellations  ISCD reserves the right to cancel the program and/or change dates of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

      ACCME Accreditation Statement

      The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

      AMA PRA Category 1 Credit(s)™

      The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

      ASRT Credit Designation 

      This activity has been approved by ASRT for 1.00 Category A continuing education credits.

      Date of Original Release and most recent Review or Update 

      This activity was most recently reviewed and released on May 22, 2023, and will expire on August 1, 2024.

      John P. Bilezikian, MD, PhD

      Vice Chair, International Education and Research

      Columbia University, Vagelos College of Physicians & Surgeons, Department of Medicine

       Disclosures: Amgen, Abiogen, Ascendis, NovoNordisk, Takeda Pharmaceuticals, Radius, Ultragenyx: Advisory Boards and Consultant Fees; Regeneron; Data and Safety Monitoring Board

      Course Planners and Managers

      Harold Rosen, MD, CCD No Financial Relationships to Disclose
      Jill Seely, BS, CMA, CAHI No Financial Relationships to Disclose
      Fiore Barbini No Financial Relationships to Disclose

      Course Content Reviewers

      Wendy Tolman-Andrews, CBDT No Financial Relationships to Disclose

      Course Faculty, Moderators, and Content Authors

      John Bilezikian, MD, PhD  - Disclosures: Amgen, Abiogen, Ascendis, NovoNordisk, Takeda Pharmaceuticals, Radius, Ultragenyx: Advisory Boards and Consultant Fees; Regeneron; Data and Safety Monitoring Board

      image

      Statement of Independence

      The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

      Disclaimer

      The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

      Disclosure of Unlabeled Use 

      This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      Privacy & Confidentiality Statement

      The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

      Attendee Cancellation Policy

      All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

      Course Changes or Cancellations

      ISCD reserves the right to cancel the program and/or change dates of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program. 

    6. DXA is critical to the assessment and management of patients with osteoporosis. We will review the current evidence on the benefits and limitations of serial DXA assessment in clinical practice.

      Activity approved for 1.00 ASRT Category A Credits
      Activity approved for up to 1.0 AMA PRA Category 1 Credits™ 
      Activity Expires June 1, 2024

      Activity Description

      DXA is critical to the assessment and management of patients with osteoporosis. We will review the current evidence on the benefits and limitations of serial DXA assessment in clinical practice.

      Learning Objectives:

      1. List ISCD positions related to least significant change (LSC) for monitoring BMD change. 2. Explain the benefits and controversies in BMD monitoring of untreated patients. 3. Explain the benefits and controversies in BMD monitoring of patients receiving anti-osteoporosis therapy.

      Instructions:

      Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

      Registration Fees

      image

      Cancellation Policy

      On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable. 

      On-Demand/Enduring Material Program Changes or Cancellations  ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

      ACCME Accreditation Statement

      The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

      AMA PRA Category 1 Credit(s)™

      The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

      ASRT Credit Designation 

      This activity has been approved by ASRT for 1.00 Category A continuing education credits.

      Date of Original Release and most recent Review or Update 

      This activity was most recently reviewed and released on April 18, 2023, and will expire on June 1, 2024.

      William Leslie, MD, MSc, CCD

      Professor of Medicine and Radiology

      University of Manitoba

      Dr. Leslie is Professor of Medicine and Radiology at the University of Manitoba with over 450 peer-reviewed publications. His research interests are in fracture risk assessment, osteoporosis testing and other nuclear diagnostic techniques. He is Past President of the International Society for Clinical Densitometry, Past Chair of the Osteoporosis Canada Scientific Advisory Council, co-led the “2010 Clinical Practice Guidelines in Osteoporosis”, Director of the Manitoba Bone Density Program, and Co-Director of the Winnipeg PET Imaging Centre.

      Disclosures: No relationships to disclose.

      Course Planners and Managers

      Fiore Barbini - No Financial Relationships to Disclose

      Jill Seely, BS, CAHI, CMA - No Financial Relationships to Disclose

      Harold Rosen, MD, CCD -  No Financial Relationships to Disclose

      Course Content Reviewers

      Wendy Tolman-Andrews -  No Financial Relationships to Disclose

      Content Authors

      Dr William Leslie, MD, FRCPC, MSc, CCD - No Financial Relationships to Disclose

      image

      Statement of Independence

      The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

      Disclaimer

      The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

      Disclosure of Unlabeled Use 

      This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      Privacy & Confidentiality Statement

      The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

      Attendee Cancellation Policy

      All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

      Course Changes or Cancellations

      ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

    7. Attendees will learn how to diagnose and manage rare bone diseases such as hypophosphatemic rickets and hypophosphatasia. Attendees can listen to a clear lecture and understand the state of the art of how to diagnose and manage rare bone diseases such as hypophosphatemic rickets and hypophosphatasia.

      Activity approved for 1.00 ASRT Category A Credits
      Activity approved for up to 1.0 AMA PRA Category 1 Credits™ 
      Activity Expires October 1, 2024

      Activity Description

      Attendees will learn how to diagnose and manage rare bone diseases such as hypophosphatemic rickets and hypophosphatasia. Attendees can listen to a clear lecture and understand the state of the art of how to diagnose and manage rare bone diseases such as hypophosphatemic rickets and hypophosphatasia.  

      Learning Objectives:

      1. The attendee will understand how to diagnose and manage hypophosphatemic rickets
      2. The attendee will understand how to diagnose and manage hypophosphatasia
      3. The attendee will understand how to diagnose and manage osteogenesis imperfecta

      Instructions:

      Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

      Registration Fees

      image

      Cancellation Policy

      On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable. 

      On-Demand/Enduring Material Program Changes or Cancellations  ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

      ACCME Accreditation Statement

      The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

      AMA PRA Category 1 Credit(s)™

      The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

      ASRT Credit Designation 

      This activity has been approved by ASRT for 1.00 Category A continuing education credits.

      Date of Original Release and most recent Review or Update 

      This activity was most recently reviewed and released on September 1, 2023, and will expire on October 1, 2024.

      Manju Chandran, MD, FACP, FACE, FAMS

      Senior Consultant and Director

      Singapore General Hospital

      Dr Manju Chandran is a Senior Consultant Endocrinologist and Director of the Osteoporosis and Bone Metabolism Unit at Singapore General Hospital (SGH).

      She is the Chairperson of the Asia Pacific Consortium on Osteoporosis (APCO), past Chairperson of the Chapter of Endocrinologists, College of Physicians, Academy of Medicine, Singapore; elected Member of the Council of Scientific Advisors and Board Member of the IOF and Deputy Chair of its Asia Pacific Regional Advisory Council; Past President of the Endocrine and Metabolic Society of Singapore, Vice Chair of the Asia Pacific Panel of the ISCD, and Treasurer of the Osteoporosis Society of Singapore. She was a Member of the Publications Committee of the ASBMR and current member of its Women In Bone and Mineral Research Committee. She has won a multitude of international awards, including the most prestigious of the IOF awards- the 2021 Olof Johnell Science Award, the IOF Committee of National Societies Medal 2015; the IOF International Young Investigator Award 2013, the SGH Most Inspiring Mentor Award 2021 and the Singhealth DUKE NUS Most Caffeinated Researcher Award 2020. OPTIMAL- the Secondary Fracture Prevention and Fracture Liaison Service she set up at SGH was the 3rd in the world and the 1st in the Asia Pacific to win the Gold Star in the IOF’s Capture the Fracture Global Map of Best Practice in 2015.

      Her research and clinical interests include the epidemiology and health economic burden of osteoporosis, rare bone disorders, diabetes and bone health and parathyroid disorders. She has close to160 publications more than ¾ of which she is the first or senior author of. She is the Section Co-Editor on Osteoporosis in the ASBMR's Primer on Metabolic Bone Diseases. She is a regular Keynote, Plenary and Symposium speaker at regional and international conferences in the fields of Endocrinology and Bone Metabolism.

      Disclosure(s): No financial relationships to disclose

      Course Planners and Managers

      Fiore Barbini - No Financial Relationships to Disclose

      Jill Seely, BS, CAHI, CMA - No Financial Relationships to Disclose

      Harold Rosen, MD, CCD -  No Financial Relationships to Disclose

      Course Content Reviewers

      Wendy Tolman-Andrews -  No Financial Relationships to Disclose

      Content Authors

      Manju Chandran, MD, FACP, FACE, FAMS- No Financial Relationships to Disclose

      image

      Statement of Independence

      The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

      Disclaimer

      The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

      Disclosure of Unlabeled Use 

      This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      Privacy & Confidentiality Statement

      The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

      Attendee Cancellation Policy

      All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

      Course Changes or Cancellations

      ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

    8. This activity was designed to allow learners to understand the relationship between radius BMD and overall fracture risk as well as the impact of wrist fractures on skeletal health. Attendees can listen to a cogent, clear, concise and well-referenced lecture after which they will understand how the role of wrist BMD in assessing skeletal fragility and predicting risk of future fractures, and its role in osteoporosis treatment decisions.

      Activity approved for 1.00 ASRT Category A Credits
      Activity approved for up to 1.0 AMA PRA Category 1 Credits™ 
      Activity Expires September 1, 2024

      Activity Description

      This activity was designed to allow learners to understand the relationship between radius BMD and overall fracture risk as well as the impact of wrist fractures on skeletal health. Attendees can listen to a cogent, clear, concise and well-referenced lecture after which they will understand how the role of wrist BMD in assessing skeletal fragility and predicting risk of future fractures, and its role in osteoporosis treatment decisions.

      Learning Objectives:

      1. Identify the relationship between radius BMD and overall fracture risk.
      2. Discuss the impact of wrist fractures on skeletal health.
      3. Describe the role of routine radius BMD in the screening algorithms for osteoporosis.

      Instructions:

      Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

      Registration Fees

      image

      Cancellation Policy

      On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable. 

      On-Demand/Enduring Material Program Changes or Cancellations  ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

      ACCME Accreditation Statement

      The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

      AMA PRA Category 1 Credit(s)™

      The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

      ASRT Credit Designation 

      This activity has been approved by ASRT for 1.00 Category A continuing education credits.

      Date of Original Release and most recent Review or Update 

      This activity was most recently reviewed and released on August 1, 2023, and will expire on September 1, 2024.

      Jane A. Cauley, DrPH

      Chair and Distinguished Professor

      University of Pittsburgh, School of Public Health, Dept of Epidemiology

      Dr. Cauley is Distinguished Professor and Interim Chair, Dept of Epidemiology, University of Pittsburgh. Dr. Cauley has been involved in osteoporosis research for over 30 yrs and is the Past-President of the American Society for Bone and Mineral Research (ASBMR). Dr. Cauley is the PI of the Osteoporotic Fractures in Men Study at the University of Pittsburgh, since its inception. She is Dual PI of a funded RO1 entitled, Bone microarchitecture and bone strength: relationships to muscle quantity, quality and function in older adults.

      Dr. Cauley also served on several large, multi-site longitudinal studies and clinical trials focusing on issues related to aging and osteoporosis, including as PI of the Study of Osteoporotic Fractures (SOF) (10,366 women age 65+) at the Pittsburgh field site, 1986-2016. SOF evolved from a study focused on osteoporosis to an important study of aging. She was also Co-PI of the Health Aging and Body Composition Study, one of the first studies to quantify intermuscular fat and relate this to disability, fractures and mortality. She served as the clinical site PI of several major randomized clinical trials of treatments for osteoporosis including the Fracture Intervention Trial (FIT) (alendronate) and its extension, FLEX ( FIT Long-term extension study); the Health Outcomes related to Zolendronic acid-Pivotal Fracture Study( HORIZON-PFS); Multiple Outcomes of Raloxifene Evaluation (MORE); the NIA sponsored Testosterone trials and was Co-PI of the Women’s Health Initiative, serving as the Chair or Co-Chair of the Calcium Vitamin D committee for the duration of the trial. She was Chair of the recruitment committee for both the Testosterone Trials and NIA sponsored ENRGIZE trial testing whether fish oil or Losartan reduced inflammation and improved mobility. Currently, she is Co-Chair of an ASBMR Task Force examining the use of race and ethnicity in clinical algorithms related to fracture risk.

      Disclosure(s): No financial relationships to disclose

      Course Planners and Managers

      Fiore Barbini - No Financial Relationships to Disclose

      Jill Seely, BS, CAHI, CMA - No Financial Relationships to Disclose

      Wendy Tolman-Andrews -  No Financial Relationships to Disclose

      Course Content Reviewers

      Harold Rosen, MD, CCD-  No Financial Relationships to Disclose

      Content Authors

      Jane A. Cauley, DrPH - No Financial Relationships to Disclose

      image

      Statement of Independence

      The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

      Disclaimer

      The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

      Disclosure of Unlabeled Use 

      This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      Privacy & Confidentiality Statement

      The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

      Attendee Cancellation Policy

      All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

      Course Changes or Cancellations

      ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.